PATENT CLAIM ANALYSIS

Application Number: 16066574
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "234500"]

Abstract:
A novel class of fluorinated derivatives of Formula (I) have been prepared and found to be useful in the treatment of cancers and other EGFR related disorders.

Claim (Index 1):
A compound of Formula I or a pharmaceutically acceptable salt, solvate and/or prodrug thereof: wherein: R 1  is selected from aryl and heteroaryl both of which are unsubstituted or substituted with one or more substituents selected from halo, C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, CN, CF 3 , OR 6 , SR 6 , N(R 6 ) 2 , and 3-7 membered heterocycloalkyl; each R 6  is independently H, aryl, heteroaryl, C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; R 2  is selected from C 1-6 alkyl, X 1 , X 2  and X 3  are the same or different and are selected from H, halo and C 1-6 alkyl R 3  is selected from H, Y is selected from NH, O, S, SO and SO 2 ; and at least one of R 2  and R 3  comprises a difluoromethyl group or at least R 3  comprises difluoromethylene group.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14466896', '15359370', '14234514', '14002983', '14399510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7824569987773276
- 35 USC 102 Novelty (BERT): 0.5108026314695597
- Combined Prediction Score: 0.7552915620465508
- Mean Citation Score: 272.126818
- Max Citation Score: 283.61575
- Similarity Product: 226.3313296790868

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test